- Home
- ABVX vs DAVE Comparison
ABVX vs DAVE Comparison
Compare ABVX & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- DAVE
- Stock Information
- Founded
- ABVX 2013
- DAVE 2017
- Country
- ABVX France
- DAVE United States
- Employees
- ABVX N/A
- DAVE N/A
- Industry
- ABVX
- DAVE Retail: Computer Software & Peripheral Equipment
- Sector
- ABVX
- DAVE Technology
- Exchange
- ABVX Nasdaq
- DAVE Nasdaq
- Market Cap
- ABVX 722.3M
- DAVE 795.6M
- IPO Year
- ABVX N/A
- DAVE N/A
- Fundamental
- Price
- ABVX $9.50
- DAVE $80.06
- Analyst Decision
- ABVX Strong Buy
- DAVE Strong Buy
- Analyst Count
- ABVX 6
- DAVE 6
- Target Price
- ABVX $36.50
- DAVE $78.00
- AVG Volume (30 Days)
- ABVX 82.3K
- DAVE 616.6K
- Earning Date
- ABVX 09-09-2024
- DAVE 11-12-2024
- Dividend Yield
- ABVX N/A
- DAVE N/A
- EPS Growth
- ABVX N/A
- DAVE N/A
- EPS
- ABVX N/A
- DAVE 3.12
- Revenue
- ABVX $9,676,417.00
- DAVE $319,355,000.00
- Revenue This Year
- ABVX $31.67
- DAVE $26.58
- Revenue Next Year
- ABVX $1,189.66
- DAVE $18.48
- P/E Ratio
- ABVX N/A
- DAVE $25.67
- Revenue Growth
- ABVX 100.87
- DAVE 30.00
- 52 Week Low
- ABVX $8.75
- DAVE $5.60
- 52 Week High
- ABVX $17.02
- DAVE $94.96
- Technical
- Relative Strength Index (RSI)
- ABVX 34.50
- DAVE 75.16
- Support Level
- ABVX $10.27
- DAVE $37.44
- Resistance Level
- ABVX $10.79
- DAVE $94.96
- Average True Range (ATR)
- ABVX 0.36
- DAVE 5.12
- MACD
- ABVX -0.05
- DAVE 4.64
- Stochastic Oscillator
- ABVX 8.16
- DAVE 74.10
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs.